The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.